103 results on '"Duffy, Stephen J"'
Search Results
2. Long-Term Valve Durability in Patients Undergoing Transcatheter Aortic Valve Implantation
3. Harmonising Individual Patient Level Cardiac Registry Data Across the Asia Pacific Region—A Feasibility Study of In-Hospital Outcomes of STEMI Patients From the Asia Pacific Evaluation of Cardiovascular Therapies (ASPECT) Network
4. Trends and Real-World Safety of Patients Undergoing Percutaneous Coronary Intervention for Symptomatic Stable Ischaemic Heart Disease in Australia
5. Adverse 30-Day Clinical Outcomes and Long-Term Mortality Among Patients With Preprocedural Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
6. Sex-Specific Outcomes Following Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Disease: A Systematic Review and Meta-Analysis
7. Effect of Age on Clinical Outcomes in Elderly Patients (>80 Years) Undergoing Percutaneous Coronary Intervention: Insights From a Multi-Centre Australian PCI Registry
8. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis
9. Clinical Outcomes in Older Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Elevation Acute Coronary Syndromes
10. Sex Disparities in Myocardial Infarction: Biology or Bias?
11. Sex Differences in Radial Access for Percutaneous Coronary Intervention in Acute Coronary Syndrome Are Independent of Body Size
12. Transcatheter Versus Surgical Aortic Valve Replacement: An Updated Systematic Review and Meta-Analysis With a Focus on Outcomes by Sex
13. Incidence, Predictors and Clinical Outcomes of Stent Thrombosis Following Percutaneous Coronary Intervention in Contemporary Practice
14. Medium-Term Bioresorbable Scaffold Outcomes Utilising Data From an Australian Clinical Quality Registry
15. Comparison of Early Outcomes in Patients at Estimated Low, Intermediate and High Risk Undergoing Transcatheter Aortic Valve Implantation: A Multicentre Australian Experience
16. The Impact of Out-of-Hours Presentation on Clinical Outcomes in ST-Elevation Myocardial Infarction
17. Factors That Prevent Progression to Transcatheter Aortic Valve Implantation (TAVI)
18. Temporal Changes in Characteristics, Treatment and Outcomes of Heart Failure Patients Undergoing Percutaneous Coronary Intervention Findings From Melbourne Interventional Group Registry
19. Trends and Clinical Outcomes in Patients Undergoing Primary Percutaneous Revascularisation for ST-Elevation Myocardial Infarction: A Single Centre Experience
20. The Establishment of the Victorian Cardiac Outcomes Registry (VCOR): Monitoring and Optimising Outcomes for Cardiac Patients in Victoria
21. Incidence, Predictors and Outcomes of Major Bleeding in Patients Following Percutaneous Coronary Interventions in Australia
22. Mid-term Outcomes in Patients Following Transcatheter Aortic Valve Implantation in the CoreValve Australia and New Zealand Study
23. Long-Term Valve Durability in Patients Undergoing Transcatheter Aortic Valve Implantation
24. Quality Control Activities Associated with Registries in Interventional Cardiology and Surgery
25. Progress Towards a National Cardiac Procedure Database—Development of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and Melbourne Interventional Group (MIG) Registries
26. Short- and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Public and Private Hospital Settings: A Propensity-Matched Analysis
27. Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: Insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries
28. Contemporary Treatment of In-Stent Restenosis and the Incidence of Recurrent In-Stent Restenosis in the Era of Drug-Eluting Stents
29. Comparison of the Clinical Characteristics and Mortality of Patients with Cardiogenic Shock Undergoing Coronary Artery Bypass Grafting Compared With Percutaneous Coronary Intervention—An Insight From 2 Multi-Centre Registries
30. Clinical Characteristics and Mortality of Patients With Multivessel Coronary Disease Undergoing Coronary Artery Bypass Grafting Compared With Percutaneous Coronary Intervention: A Comparison Between 2 Multi-Centre Registries
31. Comparison of Percutaneous Coronary Intervention And Coronary Artery Bypass Grafting for Revascularisation of Patients With Diabetes Mellitus
32. Predictors of 1 Year Mortality of Patients Undergoing Coronary Artery Bypass Grafting (CABG) Compared to Percutaneous Coronary Intervention (PCI)—Insights From 2 Large Multi-Centre Australian Registries
33. High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes
34. Validation of the Mayo Clinic Risk Score for in-hospital complications after percutaneous coronary intervention in the drug-eluting stent era using the Melbourne Interventional Group Registry
35. Comparative outcomes of staged multiple territory versus single-procedure multiple territory percutaneous coronary interventions (PCI)
36. Percutaneous Aortic Valve Replacement is Associated with Improved Myocardial Function Detectable by 2D Strain
37. Clinical outcomes in patients undergoing rescue PCI compared with primary PCI (PPCI) in STEMI
38. Lower extremity peripheral vascular disease is an independent predictor of adverse outcomes after percutaneous coronary intervention
39. Post-procedural renal failure following percutaneous coronary intervention is associated with increased early and late mortality
40. Clopidogrel preloading in STEMI treated with PCI improves infarct artery patency and short-term clinical outcomes
41. Impact of socioeconomic status on medication compliance and major adverse cardiac events following PCI
42. Procedural Glycoprotein IIb/IIIa inhibitor (GPIIb/IIIa) use in patients with ST-elevation myocardial infraction (STEMI) who undergo primary percutaneous coronary intervention (PPCI) without clopidogrel pretreatment
43. Primary percutaneous coronary intervention (PPCI) in ST-elevation myocardial infarction (STEMI): Use of peri-procedural Glycoprotein IIb/IIIa inhibitors (GPIIb/IIIa) in patients already pre-treated with clopidogrel
44. Impact of peri-procedural atrial fibrillation (AF) on short-term clinical outcomes following percutaneous coronary intervention (PCI)
45. Sirolimus- and Paxlitaxel-eluting Stents Yield Similar Clinical Outcomes when used for Selected High Risk Indications Only: Results from a Large Australian Registry
46. Predictors of 1-Year Mortality of Patients Undergoing Coronary Artery Bypass Grafting (CABG) Compared to Percutaneous Coronary Intervention (PCI)—Insights From Two Large Multi-centre Australian Registries
47. Clinical Outcome of Percutaneous Coronary Intervention (PCI) using ≤2.5mm Drug-Eluting Stents (DES): Insights from the Melbourne Interventional Group (MIG) Registry
48. Hospital Length of Stay in Patients Undergoing Percutaneous Coronary Intervention
49. Prevalence of Smoking and Adherence to Lipid-lowering Therapy in Patients Following Percutaneous Coronary Intervention
50. Clinical Characteristics and Mortality of Patients with Multi-vessel Coronary Disease (MVD) Undergoing Coronary Artery Bypass Grafting (CABG) Compared with Percutaneous Coronary Intervention (PCI)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.